aclacinomycin has been researched along with carbazilquinone in 3 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (carbazilquinone) | Trials (carbazilquinone) | Recent Studies (post-2010) (carbazilquinone) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 196 | 16 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M | 1 |
| Kanematsu, T; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
| Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K | 1 |
3 other study(ies) available for aclacinomycin and carbazilquinone
| Article | Year |
|---|---|
Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Topics: Aclarubicin; Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Stomach Neoplasms | 1992 |
Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Succinate Dehydrogenase | 1988 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Fluorouracil; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Naphthacenes; Stomach Neoplasms; Succinate Dehydrogenase | 1987 |